Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
04/2005
04/28/2005US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
04/27/2005EP1525235A1 Microstructure chain transfer agents for anionic polymerization
04/27/2005CN1198782C Pure beta-hydroxyethoxyacetic acid salt, pure 2-p-dioxaneone, and prodn. method thereof
04/26/2005CA2213124C Benzoyl derivatives
04/21/2005US20050085530 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
04/21/2005US20050085426 Acid-sensitive compounds, preparation and use thereof
04/20/2005EP1524267A1 Substituted benzylaminoalkylene heterocycles
04/20/2005EP1156042B1 Process for the preparation of glycerol carbonate
04/20/2005EP1021403B1 2,3-dioxabicyclo 3.3.1]nonane derivatives and antimalarial pharmaceutical compositions comprising them
04/20/2005CN1608058A Process for the preparation of-2(6-substituted-1, 3-dioxane-4-yl)acetic acid derivates
04/20/2005CN1197837C Method for preparing polyenoid dialdehyde monoaldehyde acetal
04/14/2005WO2005033093A1 7,8-bicycloalkyl-chroman derivatives
04/14/2005WO2005033092A1 Chroman derivatives
04/14/2005WO2005012179A3 Supercritical water or subcritical water and method of oxidizing organic substance with the same
04/14/2005US20050080277 reacting an enolates with 3-hydroxy-G-butyrolactone, to give dihydroxyoxohexanoic acids,then acylation, reducing with microorganisms, acetalization in the presence of an acid catalyst and solvolysis, to form chemical intermeadiates of 3-hydroxyl-3-methylglutaryl-coenzyme A reductase inhibitors
04/13/2005CN1606552A Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
04/13/2005CN1606543A Alpha-cyanoacrylates
04/13/2005CN1196793C Process for preparation of dihydroxy esters and derivatives thereof
04/13/2005CN1196695C Monoacetals of bicyclohexyl-4, 4-dione and their use in preparing liquid crystals
04/13/2005CN1196464C Novel coloring agent for use in oxidative hair dyeing
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030694A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/07/2005WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo
04/07/2005WO2004062590A3 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/07/2005US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials
04/07/2005CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/06/2005EP1520868A1 Degradable polydioxaneone-based materials
04/06/2005EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy
04/06/2005EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
04/06/2005EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
04/05/2005US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
04/05/2005US6875760 Glucagon antagonists/inverse agonists
03/2005
03/31/2005WO2004073606A3 Sulfonamide derivatives as ppar modulators
03/30/2005EP1517879A1 Aminoalkylphenols, methods of using and making the same
03/30/2005EP1444197B1 Novel phenyl-propargylether derivatives
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005CA2099444C Process for preparing tert-butyl (3r,5s)-6-hydroxy-3,5-o- isopropylidene-3,5-dihydroxyhexanoate
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065353 Mitosis agents; antitumor agents; anticancer agents
03/24/2005US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis
03/24/2005US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents
03/24/2005US20050065099 Treatment of mitochondrial diseases
03/23/2005EP1515962A1 Process for the preaparation of dioxane acetic acid esters
03/23/2005EP1515931A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media
03/23/2005CN1193998C Mfg, Method of cyclic diester using fermented lactic acid as raw materila and method for mfg, polylacgtic acid
03/22/2005US6870059 Acetalization of heterocyclic esters in the presence of acid catalyst, to form compounds such as 2-(6-hydroxymethyl-1,3-dioxane-4-yl)acetic acid, t-butyl ester, used as chemical intermediates for statins
03/22/2005US6870058 Polyhydroxy, dienyl lactones and intermediates
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023793A2 Direct synthesis of di-heteroatom containing cyclic organic compounds
03/17/2005WO2004110418A3 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
03/17/2005US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005CN1594313A Process for continuous preparation of lactide
03/16/2005CN1594312A Process for preparation of lactide by using ionic liquid as catalyst
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050053861 Onium salt compound and radiation-sensitive resin composition
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005CN1592768A Fluorescent pigments
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/08/2005US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/08/2005US6864225 Cyclic ketals, fragrance compositions containing the same and methods of using the same
03/08/2005US6863782 Method of preparing di(ketene acetals)
03/08/2005US6863211 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
03/03/2005WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors
03/03/2005WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF
03/03/2005US20050049300 Converting the carboxyl group of a thromboxane ligand to an amide or amine to obtain an ocular hypotensive agent; mimic the vasoconstrictor properties of thromboxane A2 and its endoperoxide precursors, without causing concomitant platelet aggregation; post-surgery and post laser treatment
03/03/2005US20050049235 Amino ceramide-like compounds and therapeutic methods of use
03/03/2005US20050048395 Homopolymer or copolymer of polyhydroxystyrene changes its solubility in an alkali developer by action of an acid; generating an acid by exposure to radiation; bis((4-(1,3-dioxolan-2-yl)cyclohexyl)methylsulfonyl)diazomethane
03/02/2005EP1509509A1 Glucagon antagonists/inverse agonists
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005CN1589153A Preventives/remedies for urinary disturbance
03/01/2005US6861538 Process for the preparation of cyclic lactic acid oligomer
02/2005
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005US20050043532 Dehydration, dehydrosulfurization or deamination and ring closure of aqueous bis(2-hydroxyethyl)ethers, amines, or sulfides, bis(2-mercaptoethyl)ethers, amines, or sulfides, and bis(2-aminoethyl)ethers, amines or sulfides by heating under autogeneous pressure
02/24/2005US20050043396 Acetalization of N-benzoylamino glycol with 1,1,3,3-teramethoxy glycol; protein kinase C inhibitors
02/24/2005US20050043364 Novel pyrrole-based HMG-CoA reductase inhibitors
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
02/23/2005CN1585742A Aryl aniline beta-2 adrenergic receptor agonists
02/23/2005CN1583740A Method for preparing lactide by microwave radiation
02/23/2005CN1583739A Improvement for 18F-FMISO mark forebody synthetic method
02/17/2005WO2005014539A2 Pyrrole-based hmg-coa reductase inhibitors
02/17/2005WO2005013928A1 Composition and method for promoting hair growth
02/17/2005US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization
02/17/2005DE19946228B4 Verfahren zur Herstellung eines Benzol-Derivates Process for the preparation of a benzene derivative
02/17/2005CA2534645A1 Composition and method for promoting hair growth
02/17/2005CA2534494A1 Pyrrole-based hmg-coa reductase inhibitors
02/16/2005EP1506962A2 Nitrogen-containing aromatic heterocycles
02/16/2005EP1506182A1 Methods for the manufacture of dihydro-furan-2-one derivatives
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 103